COLLECTING DUCT RENAL CELL CARCINOMA
Clinical trials for COLLECTING DUCT RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy trial targets Tough-to-Treat kidney cancers
Disease control OngoingThis study is testing whether combining three medications—cabozantinib, nivolumab, and ipilimumab—can safely slow the growth of advanced kidney cancer that has spread. The trial will enroll about 60 adults with specific types of non-clear cell kidney cancer that cannot be surgica…
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug duo targets Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing whether combining two existing cancer drugs, nivolumab and cabozantinib, is safe and effective for people with advanced non-clear cell kidney cancer that has spread. The trial will enroll about 60 adults who have had limited prior treatment to see if the com…
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC